Skip to search formSkip to main contentSkip to account menu

CGP 4832

Known as: CGP-4832, Rifamycin, 25-O-deacetyl-1,4-dideoxy-1,4-dihydro-25-O-(3-((1-methyl-3-piperidinyl)methoxy)-1,3-dioxopropyl)-3-(4-morpholinyl)-1,4-dioxo- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Rifamycins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
OF ANTIBIOTICS CGP 4832 , A NEW SEMISYNTHETIC RIFAMYCIN DERIVATIVE HIGHLY ACTIVE AGAINST SOME GRAM-NEGATIVE BACTERIA
Chemical Methods Organic solutions were dried with anhydrous sodium sulfate. Evaporation was carried out under water-jet vacuum… 
2003
2003
Active transport of antibiotics across the outer membrane of gram-negative bacteria and its implications in the development of new antibiotics
The outer membrane of gram-negative bacteria forms a permeability barrier that usually reduces the access of antibiotics to… 
1987
1987
CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria.
CGP 4832 (5) is a new derivative of rifamycin S, showing a very high degree of activity against certain Gram-negative bacteria… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)